Business · 30/06/2005Updated: 10/17/2026 · 1 min read
FDA Releases Revised Guidance on Donor Suitability and Blood Safety in West Nile Virus Cases
Summary
The Food and Drug Administration (FDA) has published a revised guidance document to assess donor suitability and blood product safety in cases of known or suspected West Nile Virus (WNV) infection, updating deferral periods and component retrieval procedures.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →